{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:42:41Z","timestamp":1794998561131,"version":"4.9.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Pioneered by the Mayo Clinic, multimodal therapy with neoadjuvant chemoradiotherapy and orthotopic liver transplant has emerged as a promising option for unresectable hilar cholangiocarcinoma (hCCA). This study reports the experience of the Irish National Liver Transplant Programme with the Mayo Protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>All patients diagnosed with unresectable hCCA between 2004 and 2016, who were eligible for the treatment protocol, were prospectively studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Thirty-seven patients commenced chemoradiotherapy. Of those, 11 were excluded due to disease progression and 26 proceeded to liver transplantation. There were 24 males, the median age was 49, and 88% had underlying primary sclerosing cholangitis. R0 and pathologic complete response rates were 96% and 62%, respectively. Overall median survival was 53 months and 1-, 3-, and 5-year survival was 81%, 69%, and 55%, respectively. The median survival of patients achieving a pathologic complete response was 83.8 months compared with 20.9 months in the group with residual disease (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.036). Six patients (23%) developed disease recurrence. Among the patients who developed metastatic disease during neoadjuvant treatment, median survival was 10.5 months compared with 53 months in patients who proceeded to transplant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Neoadjuvant chemoradiotherapy followed by liver transplantation substantially increases the survival of patients with unresectable hCCA. Achieving a pathologic complete response confers a significant survival benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000003114","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T11:21:14Z","timestamp":1579173674000},"page":"2097-2104","source":"Crossref","is-referenced-by-count":40,"title":["Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol"],"prefix":"10.1097","volume":"104","author":[{"given":"Alexandra","family":"Zaborowski","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Heneghan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fiore","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Stafford","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Gallagher","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Geoghegan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal","family":"Maguire","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emir","family":"Hoti","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Liver Transplant Surgery, St. Vincent\u2019s University Hospital, Elm Park, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4251\/wjgo.v5.i7.132","article-title":"Risk factors and classifications of hilar cholangiocarcinoma.","volume":"5","author":"Suarez-Munoz","year":"2013","journal-title":"World J Gastrointest Oncol"},{"key":"R2-20231002","first-page":"18","article-title":"Hilar cholangiocarcinoma: diagnosis, treatment options, and management.","volume":"3","author":"Soares","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/hpb.12450","article-title":"Hilar cholangiocarcinoma: expert consensus statement.","volume":"17","author":"Mansour","year":"2015","journal-title":"HPB (Oxford)"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections.","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann Surg"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5009\/gnl15568","article-title":"Cholangiocarcinoma: current knowledge and new developments.","volume":"11","author":"Blechacz","year":"2017","journal-title":"Gut Liver"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.surg.2017.08.011","article-title":"Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.","volume":"163","author":"Komaya","year":"2018","journal-title":"Surgery"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jamcollsurg.2015.09.005","article-title":"Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection.","volume":"221","author":"Groot Koerkamp","year":"2015","journal-title":"J Am Coll Surg"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2214\/AJR.07.3992","article-title":"Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography.","volume":"191","author":"Choi","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/00007890-200004270-00019","article-title":"Liver transplantation for cholangiocarcinoma: results in 207 patients.","volume":"69","author":"Meyer","year":"2000","journal-title":"Transplantation"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000108702.45715.81","article-title":"Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma.","volume":"239","author":"Robles","year":"2004","journal-title":"Ann Surg"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/lv.2000.6143","article-title":"Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.","volume":"6","author":"De Vreede","year":"2000","journal-title":"Liver Transpl"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma.","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin Liver Dis"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma.","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/13651820801992542","article-title":"Surgery for cholangiocarcinoma: the role of liver transplantation.","volume":"10","author":"Rosen","year":"2008","journal-title":"HPB (Oxford)"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jamcollsurg.2012.03.014","article-title":"Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?","volume":"215","author":"Rosen","year":"2012","journal-title":"J Am Coll Surg"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/SLA.0000000000002716","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting paradigms for resectable disease in annals of surgery 2018.","volume":"267","author":"Rosen","year":"2018","journal-title":"Ann Surg"},{"issue":"Suppl 3","key":"R18-20231002","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1002\/lt.20965","article-title":"Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.","volume":"12","author":"Gores","year":"2006","journal-title":"Liver Transpl"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/hpb.12082","article-title":"Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience.","volume":"16","author":"Duignan","year":"2014","journal-title":"HPB (Oxford)"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","article-title":"Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.","volume":"82","author":"Heimbach","year":"2006","journal-title":"Transplantation"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hep.25629","article-title":"Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma.","volume":"56","author":"Darwish Murad","year":"2012","journal-title":"Hepatology"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/PAS.0000000000000588","article-title":"Prognostic significance of the histologic response of perihilar cholangiocarcinoma to preoperative neoadjuvant chemoradiation in liver explants.","volume":"40","author":"Lehrke","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/lt.22462","article-title":"Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.","volume":"18","author":"Panjala","year":"2012","journal-title":"Liver Transpl"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/MEG.0b013e3283396dde","article-title":"Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma.","volume":"22","author":"Cassier","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000337289","article-title":"Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.","volume":"58","author":"Pracht","year":"2012","journal-title":"Chemotherapy"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1432-2277.2010.01108.x","article-title":"Liver transplantation for cholangiocarcinoma.","volume":"23","author":"Rosen","year":"2010","journal-title":"Transpl Int"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease.","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2018.06.010","article-title":"Impact of daas on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.","volume":"69","author":"Belli","year":"2018","journal-title":"J Hepatol"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4254\/wjh.v7.i10.1355","article-title":"Review on immunosuppression in liver transplantation.","volume":"7","author":"Moini","year":"2015","journal-title":"World J Hepatol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:47:36Z","timestamp":1696211256000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003114","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737267155.793579669","asserted-by":"object"}]},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,13]]}}}